Details for New Drug Application (NDA): 201445
✉ Email this page to a colleague
The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for 201445
Tradename: | ACYCLOVIR |
Applicant: | Cadila Pharms Ltd |
Ingredient: | acyclovir |
Patents: | 0 |
Pharmacology for NDA: 201445
Mechanism of Action | DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 201445
Suppliers and Packaging for NDA: 201445
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACYCLOVIR | acyclovir | CAPSULE;ORAL | 201445 | ANDA | RedPharm Drug, Inc. | 67296-1723 | 67296-1723-7 | 35 CAPSULE in 1 BOTTLE (67296-1723-7) |
ACYCLOVIR | acyclovir | CAPSULE;ORAL | 201445 | ANDA | Cadila Pharmaceuticals Limited | 71209-004 | 71209-004-05 | 100 CAPSULE in 1 BOTTLE (71209-004-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Mar 6, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription